首页> 美国卫生研究院文献>Stem Cells Translational Medicine >The Generation of Human γδT Cell‐Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture
【2h】

The Generation of Human γδT Cell‐Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture

机译:从人外周血单个核细胞培养物中产生人γδT细胞诱导的多能干细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

γδT cells constitute a small proportion of lymphocytes in peripheral blood. Unlike αβT cells, the anti‐tumor activities are exerted through several different pathways in a MHC‐unrestricted manner. Thus, immunotherapy using γδT cells is considered to be effective for various types of cancer. Occasionally, however, ex vivo expanded cells are not as effective as expected due to cell exhaustion. To overcome the issue of T‐cell exhaustion, researchers have generated induced pluripotent stem cells (iPSCs) that harbor the same T‐cell receptor (TCR) genes as their original T‐cells, which provide nearly limitless sources for antigen‐specific cytotoxic T lymphocytes (CTLs). However, these technologies have focused on αβT cells and require a population of antigen‐specific CTLs, which are purified by cell sorting with HLA‐peptide multimer, as the origin of iPS cells. In the present study, we aimed to develop an efficient and convenient system for generating iPSCs that harbor rearrangements of the TCRG and TCRD gene regions (γδT‐iPSCs) without cell‐sorting. We stimulated human whole peripheral blood mononuclear cell (PBMC) culture using Interleukin‐2 and Zoledronate to activate γδT cells. Gene transfer into those cells with the Sendai virus vector resulted in γδT cell‐dominant expression of exogenous genes. The introduction of reprogramming factors into the stimulated PBMC culture allowed us to establish iPSC lines. Around 70% of the established lines carried rearrangements at the TCRG and TCRD gene locus. The γδT‐iPSCs could differentiate into hematopoietic progenitors. Our technology will pave the way for new avenues toward novel immunotherapy that can be applied for various types of cancer. stem cells translational medicine 2018;7:34–44
机译:γδT细胞占外周血淋巴细胞的一小部分。与αβT细胞不同,抗肿瘤活性通过MHC不受限制的方式通过几种不同的途径发挥作用。因此,使用γδT细胞的免疫疗法被认为对各种类型的癌症有效。但是,有时由于细胞衰竭,离体扩增的细胞效果不如预期。为了克服T细胞衰竭的问题,研究人员已经产生了诱导性多能干细胞(iPSC),该干细胞具有与原始T细胞相同的T细胞受体(TCR)基因,从而为抗原特异性细胞毒性T提供了几乎无限的来源。淋巴细胞(CTL)。但是,这些技术专注于αβT细胞,并需要大量的抗原特异性CTL,这些细胞是通过使用HLA肽多聚体进行细胞分选而纯化的,作为iPS细胞的起源。在本研究中,我们旨在开发一种高效便捷的系统,以生成不带细胞分选的,包含TCRG和TCRD基因区域(γδT-iPSCs)重排的iPSC。我们使用白介素-2和唑来膦酸盐刺激人全外周血单核细胞(PBMC)培养以激活γδT细胞。通过仙台病毒载体将基因转移到这些细胞中,导致γδT细胞主要表达外源基因。将重编程因子引入刺激的PBMC培养物中,使我们能够建立iPSC品系。已建立的品系中约有70%在TCRG和TCRD基因位点进行重排。 γδT-iPSCs可以分化为造血祖细胞。我们的技术将为可应用于各种类型癌症的新型免疫疗法铺平道路。干细胞转化医学2018; 7:34–44

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号